breast cancer

What did the MARIANNE trial assess for Her2+ metastatic breast cancer ?
TDM-1 plus pertuzumab versus trastuzumab + docetaxel, showed similar efficacy (non-inferior but not superior) with less discontinuation

en_USEnglish